BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37296669)

  • 1. TREM2 Agonism with a Monoclonal Antibody Attenuates Tau Pathology and Neurodegeneration.
    Fassler M; Benaim C; George J
    Cells; 2023 Jun; 12(11):. PubMed ID: 37296669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo.
    Lee-Gosselin A; Jury-Garfe N; You Y; Dabin L; Soni D; Dutta S; Rochet JC; Kim J; Oblak AL; Lasagna-Reeves CA
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology.
    Lee SH; Meilandt WJ; Xie L; Gandham VD; Ngu H; Barck KH; Rezzonico MG; Imperio J; Lalehzadeh G; Huntley MA; Stark KL; Foreman O; Carano RAD; Friedman BA; Sheng M; Easton A; Bohlen CJ; Hansen DV
    Neuron; 2021 Apr; 109(8):1283-1301.e6. PubMed ID: 33675684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.
    Leyns CEG; Ulrich JD; Finn MB; Stewart FR; Koscal LJ; Remolina Serrano J; Robinson GO; Anderson E; Colonna M; Holtzman DM
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11524-11529. PubMed ID: 29073081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triggering receptor expressed on myeloid cells 2 deficiency exacerbates injury-induced inflammation in a mouse model of tauopathy.
    Katsumoto A; Kokiko-Cochran ON; Bemiller SM; Xu G; Ransohoff RM; Lamb BT
    Front Immunol; 2022; 13():978423. PubMed ID: 36389767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intersection of pathological tau and microglia at the synapse.
    Vogels T; Murgoci AN; Hromádka T
    Acta Neuropathol Commun; 2019 Jul; 7(1):109. PubMed ID: 31277708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease.
    Zhao P; Xu Y; Jiang L; Fan X; Li L; Li X; Arase H; Zhao Y; Cao W; Zheng H; Xu H; Tong Q; Zhang N; An Z
    Sci Transl Med; 2022 Sep; 14(661):eabq0095. PubMed ID: 36070367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice.
    Jiang T; Tan L; Zhu XC; Zhou JS; Cao L; Tan MS; Wang HF; Chen Q; Zhang YD; Yu JT
    Neurobiol Aging; 2015 Dec; 36(12):3176-3186. PubMed ID: 26364736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trem2 deletion enhances tau dispersion and pathology through microglia exosomes.
    Zhu B; Liu Y; Hwang S; Archuleta K; Huang H; Campos A; Murad R; Piña-Crespo J; Xu H; Huang TY
    Mol Neurodegener; 2022 Sep; 17(1):58. PubMed ID: 36056435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology.
    Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C;
    Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer's disease models.
    Fassler M; Rappaport MS; Cuño CB; George J
    J Neuroinflammation; 2021 Jan; 18(1):19. PubMed ID: 33422057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy.
    Bemiller SM; McCray TJ; Allan K; Formica SV; Xu G; Wilson G; Kokiko-Cochran ON; Crish SD; Lasagna-Reeves CA; Ransohoff RM; Landreth GE; Lamb BT
    Mol Neurodegener; 2017 Oct; 12(1):74. PubMed ID: 29037207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TREM2 in Alzheimer's Disease: A Long Road Ahead.
    Kulkarni B; Kumar D; Cruz-Martins N; Sellamuthu S
    Mol Neurobiol; 2021 Oct; 58(10):5239-5252. PubMed ID: 34275100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration.
    Gratuze M; Leyns CE; Sauerbeck AD; St-Pierre MK; Xiong M; Kim N; Serrano JR; Tremblay MÈ; Kummer TT; Colonna M; Ulrich JD; Holtzman DM
    J Clin Invest; 2020 Sep; 130(9):4954-4968. PubMed ID: 32544086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response.
    Jiang T; Zhang YD; Gao Q; Ou Z; Gong PY; Shi JQ; Wu L; Zhou JS
    Inflammation; 2018 Jun; 41(3):811-823. PubMed ID: 29362997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant
    Cheng Q; Danao J; Talreja S; Wen P; Yin J; Sun N; Li CM; Chui D; Tran D; Koirala S; Chen H; Foltz IN; Wang S; Sambashivan S
    J Biol Chem; 2018 Aug; 293(32):12620-12633. PubMed ID: 29599291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
    Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
    Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.
    Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR
    Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.